{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:04:27Z","timestamp":1783094667765,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Suzhou Clinical Medical Center for Mood Disorders","award":["Szlcyxzx202109"],"award-info":[{"award-number":["Szlcyxzx202109"]}]},{"name":"Suzhou Key Laboratory","award":["SZS2024016"],"award-info":[{"award-number":["SZS2024016"]}]},{"name":"Suzhou Multicenter Clinical Research Project on Major Diseases","award":["DZXYJ202413, MR-32-25-054378"],"award-info":[{"award-number":["DZXYJ202413, MR-32-25-054378"]}]},{"name":"Suzhou Municipal Key Project for Applied Basic Research in Medical and Health Sciences","award":["SYW2025022"],"award-info":[{"award-number":["SYW2025022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07736-w","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:25:23Z","timestamp":1766395523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interrelationships among oxidative stress, niacin response, cognition, and symptoms in chronic schizophrenia: a case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Lihua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"7736_CR1","doi-asserted-by":"crossref","unstructured":"Global, regional, and, national, burden, of, 12, mental, disorders, in, 204, countries, and, territories, 1990\u20132019:, a, systematic, analysis, for, the, global, burden, of, disease, study, 2019. Lancet Psychiatry. 2022;;92::137\u201350.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"issue":"2\u20133","key":"7736_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.schres.2010.09.015","volume":"125","author":"RS Keefe","year":"2011","unstructured":"Keefe RS, Fox KH, Harvey PD, Cucchiaro J, Siu C, Loebel A. Characteristics of the MATRICS consensus cognitive battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res. 2011;125(2\u20133):161\u20138.","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"7736_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.schres.2013.02.026","volume":"146","author":"CZ Burton","year":"2013","unstructured":"Burton CZ, Vella L, Harvey PD, Patterson TL, Heaton RK, Twamley EW. Factor structure of the MATRICS consensus cognitive battery (MCCB) in schizophrenia. Schizophr Res. 2013;146(1\u20133):244\u20138.","journal-title":"Schizophr Res"},{"key":"7736_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neubiorev.2019.07.020","volume":"105","author":"TF Halverson","year":"2019","unstructured":"Halverson TF, Orleans-Pobee M, Merritt C, Sheeran P, Fett AK, Penn DL. Pathways to functional outcomes in schizophrenia spectrum disorders: Meta-analysis of social cognitive and neurocognitive predictors. Neurosci Biobehav Rev. 2019;105:212\u20139.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"7736_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12325-012-0001-4","volume":"29","author":"H Kitchen","year":"2012","unstructured":"Kitchen H, Rofail D, Heron L, Sacco P. Cognitive impairment associated with schizophrenia: a review of the humanistic burden. Adv Ther. 2012;29(2):148\u201362.","journal-title":"Adv Ther"},{"key":"7736_CR6","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1016\/j.scog.2021.100233","volume":"28","author":"A Kadakia","year":"2022","unstructured":"Kadakia A, Fan Q, Shepherd J, Dembek C, Bailey H, Walker C, Williams GR. Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia. Schizophr Res Cogn. 2022;28:100233.","journal-title":"Schizophr Res Cogn"},{"issue":"7","key":"7736_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/archgenpsychiatry.2010.69","volume":"67","author":"MJ Owen","year":"2010","unstructured":"Owen MJ, Craddock N, O\u2019Donovan MC. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch Gen Psychiatry. 2010;67(7):667\u201373.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"7736_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/schbul\/sbt108","volume":"39","author":"JJ McGrath","year":"2013","unstructured":"McGrath JJ, Mortensen PB, Visscher PM, Wray NR. Where GWAS and epidemiology meet: opportunities for the simultaneous study of genetic and environmental risk factors in schizophrenia. Schizophr Bull. 2013;39(5):955\u20139.","journal-title":"Schizophr Bull"},{"issue":"3","key":"7736_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/YCO.0000000000000054","volume":"27","author":"FE Emiliani","year":"2014","unstructured":"Emiliani FE, Sedlak TW, Sawa A. Oxidative stress and schizophrenia: recent breakthroughs from an old story. Curr Opin Psychiatry. 2014;27(3):185\u201390.","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"7736_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.schres.2015.06.022","volume":"176","author":"M Koga","year":"2016","unstructured":"Koga M, Serritella AV, Sawa A, Sedlak TW. Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr Res. 2016;176(1):52\u201371.","journal-title":"Schizophr Res"},{"key":"7736_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mito.2020.11.009","volume":"56","author":"RC Roberts","year":"2021","unstructured":"Roberts RC. Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies. Mitochondrion. 2021;56:91\u2013101.","journal-title":"Mitochondrion"},{"key":"7736_CR12","doi-asserted-by":"publisher","first-page":"108840","DOI":"10.1016\/j.abb.2021.108840","volume":"703","author":"Y Saito","year":"2021","unstructured":"Saito Y. Lipid peroxidation products as a mediator of toxicity and adaptive response - The regulatory role of Selenoprotein and vitamin E. Arch Biochem Biophys. 2021;703:108840.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"7736_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0278-5846(01)00220-2","volume":"26","author":"BK Puri","year":"2002","unstructured":"Puri BK, Hirsch SR, Easton T, Richardson AJ. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(1):49\u201352.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7736_CR14","doi-asserted-by":"crossref","unstructured":"Sitarz R, Juchnowicz D, Karaku\u0142a K, Forma A, Baj J, Rog J et al. Niacin skin flush backs-from the roots of the test to nowadays hope. J Clin Med. 2023;12(5).","DOI":"10.3390\/jcm12051879"},{"key":"7736_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.schres.2025.04.003","volume":"280","author":"CW Chiu","year":"2025","unstructured":"Chiu CW, Chen BY, Lin JJ, Tseng HH, Huang CC, Wang TY, et al. Developing a risk assessment model for treatment-resistant schizophrenia: the role of niacin receptor GPR109A and prostaglandin receptors DP(1), EP(2), and EP(4) in the niacin-induced Flushing pathway. Schizophr Res. 2025;280:30\u20138.","journal-title":"Schizophr Res"},{"issue":"6","key":"7736_CR16","first-page":"988","volume":"19","author":"XJ Xu","year":"2015","unstructured":"Xu XJ, Jiang GS. Niacin-respondent subset of schizophrenia \u2013 a therapeutic review. Eur Rev Med Pharmacol Sci. 2015;19(6):988\u201397.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2\u20133","key":"7736_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.psychres.2005.10.010","volume":"143","author":"L Bosveld-van Haandel","year":"2006","unstructured":"Bosveld-van Haandel L, Knegtering R, Kluiter H, van den Bosch RJ. Niacin skin Flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Res. 2006;143(2\u20133):303\u20136.","journal-title":"Psychiatry Res"},{"issue":"1","key":"7736_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41537-022-00252-w","volume":"8","author":"YH Yu","year":"2022","unstructured":"Yu YH, Su HM, Lin SH, Hsiao PC, Lin YT, Liu CM, et al. Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship. Schizophrenia (Heidelb). 2022;8(1):38.","journal-title":"Schizophrenia (Heidelb)"},{"issue":"2","key":"7736_CR19","doi-asserted-by":"publisher","first-page":"e100748","DOI":"10.1136\/gpsych-2022-100748","volume":"35","author":"R Gan","year":"2022","unstructured":"Gan R, Wei Y, Wu G, Zeng J, Hu Y, Xu L, et al. Attenuated niacin-induced skin flush response in individuals with clinical high risk for psychosis. Gen Psychiatr. 2022;35(2):e100748.","journal-title":"Gen Psychiatr"},{"key":"7736_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jpsychires.2025.02.059","volume":"184","author":"H Chen","year":"2025","unstructured":"Chen H, Li S, Gu Y, Liang K, Li Y, Cheng B, et al. Blunted niacin skin Flushing response in violent offenders with schizophrenia: A potential auxiliary diagnostic biomarker. J Psychiatr Res. 2025;184:249\u201355.","journal-title":"J Psychiatr Res"},{"issue":"1\u20133","key":"7736_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.schres.2012.03.001","volume":"137","author":"E Messamore","year":"2012","unstructured":"Messamore E. Niacin subsensitivity is associated with functional impairment in schizophrenia. Schizophr Res. 2012;137(1\u20133):180\u20134.","journal-title":"Schizophr Res"},{"key":"7736_CR22","doi-asserted-by":"publisher","first-page":"771144","DOI":"10.3389\/fpsyt.2021.771144","volume":"12","author":"SH Ansarey","year":"2021","unstructured":"Ansarey SH. Inflammation and jnk\u2019s role in Niacin-GPR109A diminished flushed effect in microglial and neuronal cells with relevance to schizophrenia. Front Psychiatry. 2021;12:771144.","journal-title":"Front Psychiatry"},{"key":"7736_CR23","doi-asserted-by":"publisher","first-page":"103239","DOI":"10.1016\/j.ebiom.2021.103239","volume":"64","author":"X Yang","year":"2021","unstructured":"Yang X, Li M, Jiang J, Hu X, Qing Y, Sun L, et al. Dysregulation of phospholipase and cyclooxygenase expression is involved in schizophrenia. EBioMedicine. 2021;64:103239.","journal-title":"EBioMedicine"},{"issue":"2","key":"7736_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/schbul\/sbv130","volume":"42","author":"JK Yao","year":"2016","unstructured":"Yao JK, Dougherty GG Jr., Gautier CH, Haas GL, Condray R, Kasckow JW, et al. Prevalence and specificity of the abnormal niacin response: A potential endophenotype marker in schizophrenia. Schizophr Bull. 2016;42(2):369\u201376.","journal-title":"Schizophr Bull"},{"key":"7736_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.schres.2021.02.009","volume":"230","author":"DD Wang","year":"2021","unstructured":"Wang DD, Hu XW, Jiang J, Sun LY, Qing Y, Yang XH, et al. Attenuated and delayed niacin skin Flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker. Schizophr Res. 2021;230:53\u201360.","journal-title":"Schizophr Res"},{"issue":"4","key":"7736_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0924-977X(97)00089-8","volume":"8","author":"C Bouwer","year":"1998","unstructured":"Bouwer C, Stein DJ. Hyperresponsivity to nicotinic acid challenge in generalized social phobia: a pilot study. Eur Neuropsychopharmacol. 1998;8(4):311\u20133.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"7736_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","volume":"11","author":"JF Wang","year":"2009","unstructured":"Wang JF, Shao L, Sun X, Young LT. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009;11(5):523\u20139.","journal-title":"Bipolar Disord"},{"key":"7736_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2016.12.046","volume":"111","author":"A Romano","year":"2017","unstructured":"Romano A, Serviddio G, Calcagnini S, Villani R, Giudetti AM, Cassano T, Gaetani S. Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal. Free Radic Biol Med. 2017;111:281\u201393.","journal-title":"Free Radic Biol Med"},{"key":"7736_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/7854_2018_88","volume":"44","author":"R Upthegrove","year":"2020","unstructured":"Upthegrove R, Khandaker GM. Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Curr Top Behav Neurosci. 2020;44:49\u201366.","journal-title":"Curr Top Behav Neurosci"},{"key":"7736_CR30","doi-asserted-by":"publisher","first-page":"703452","DOI":"10.3389\/fpsyt.2021.703452","volume":"12","author":"AJ Murray","year":"2021","unstructured":"Murray AJ, Rogers JC, Katshu M, Liddle PF, Upthegrove R. Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders. Front Psychiatry. 2021;12:703452.","journal-title":"Front Psychiatry"},{"key":"7736_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fpsyt.2018.00622","volume":"9","author":"NE MacKenzie","year":"2018","unstructured":"MacKenzie NE, Kowalchuk C, Agarwal SM, Costa-Dookhan KA, Caravaggio F, Gerretsen P, et al. Antipsychotics, metabolic adverse Effects, and cognitive function in schizophrenia. Front Psychiatry. 2018;9:622.","journal-title":"Front Psychiatry"},{"key":"7736_CR32","doi-asserted-by":"crossref","unstructured":"Ohi K, Sumiyoshi C, Fujino H, Yasuda Y, Yamamori H, Fujimoto M et al. Genetic overlap between general cognitive function and schizophrenia: a review of cognitive GWASs. Int J Mol Sci. 2018;19(12).","DOI":"10.3390\/ijms19123822"},{"issue":"1","key":"7736_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12888-024-06335-5","volume":"24","author":"D Li","year":"2024","unstructured":"Li D, Huang Y, Lu H, Zhou S, Feng S, Li H, et al. Association between cognitive function, antioxidants, and clinical variables in Chinese patients with schizophrenia. BMC Psychiatry. 2024;24(1):912.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"7736_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","volume":"62","author":"E Messamore","year":"2003","unstructured":"Messamore E, Hoffman WF, Janowsky A. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr Res. 2003;62(3):251\u20138.","journal-title":"Schizophr Res"},{"issue":"5\u20136","key":"7736_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.plefa.2009.09.003","volume":"81","author":"BM Nilsson","year":"2009","unstructured":"Nilsson BM, Hultman CM, Ekselius L. Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia. Prostaglandins Leukot Essent Fat Acids. 2009;81(5\u20136):367\u201372.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"1\u20133","key":"7736_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025","volume":"122","author":"E Messamore","year":"2010","unstructured":"Messamore E, Hoffman WF, Yao JK. Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res. 2010;122(1\u20133):248\u201356.","journal-title":"Schizophr Res"},{"issue":"1","key":"7736_CR37","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1186\/s12888-025-07560-2","volume":"25","author":"M Yang","year":"2025","unstructured":"Yang M, Tian Q, Yuan X, Liu D, Shi Q, Yang H, Zhang X. Correlations of oxidative stress markers with niacin sensitivity in male patients with chronic schizophrenia. BMC Psychiatry. 2025;25(1):1092.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"7736_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2008.04.044","volume":"202","author":"SH Ganji","year":"2009","unstructured":"Ganji SH, Qin S, Zhang L, Kamanna VS, Kashyap ML. Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis. 2009;202(1):68\u201375.","journal-title":"Atherosclerosis"},{"key":"7736_CR39","doi-asserted-by":"crossref","unstructured":"Bernier F, Kuhara T, Xiao J. Probiotic bifidobacterium breve MCC1274 protects against oxidative stress and neuronal lipid droplet formation via PLIN4 gene regulation. Microorganisms. 2023;11(3).","DOI":"10.3390\/microorganisms11030791"},{"issue":"4","key":"7736_CR40","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E. Oxidative Stress, synaptic Dysfunction, and alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1105\u201321.","journal-title":"J Alzheimers Dis"},{"key":"7736_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","volume":"107","author":"A Ionescu-Tucker","year":"2021","unstructured":"Ionescu-Tucker A, Cotman CW. Emerging roles of oxidative stress in brain aging and alzheimer\u2019s disease. Neurobiol Aging. 2021;107:86\u201395.","journal-title":"Neurobiol Aging"},{"key":"7736_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2018.02.034","volume":"263","author":"L Man","year":"2018","unstructured":"Man L, Lv X, Du XD, Yin G, Zhu X, Zhang Y, et al. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia. Psychiatry Res. 2018;263:1\u20136.","journal-title":"Psychiatry Res"},{"issue":"5","key":"7736_CR43","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28(5):1902\u201318.","journal-title":"Mol Psychiatry"},{"key":"7736_CR44","doi-asserted-by":"crossref","unstructured":"Rek-Owodzi\u0144 K, Tyburski E, Plichta P, Waszczuk K, Bielecki M, Wietrzy\u0144ski K et al. The relationship between cognitive functions and psychopathological symptoms in first episode psychosis and chronic schizophrenia. J Clin Med. 2022;11(9).","DOI":"10.3390\/jcm11092619"},{"issue":"4","key":"7736_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1192\/bjp.bp.108.060723","volume":"195","author":"TK Rajji","year":"2009","unstructured":"Rajji TK, Ismail Z, Mulsant BH. Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry. 2009;195(4):286\u201393.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"7736_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/00048674.2010.541418","volume":"45","author":"VP Bozikas","year":"2011","unstructured":"Bozikas VP, Andreou C. Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Aust N Z J Psychiatry. 2011;45(2):93\u2013108.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"7736_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/JGP.0b013e31823bc08c","volume":"20","author":"DA Loewenstein","year":"2012","unstructured":"Loewenstein DA, Czaja SJ, Bowie CR, Harvey PD. Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults. Am J Geriatr Psychiatry. 2012;20(1):29\u201340.","journal-title":"Am J Geriatr Psychiatry"},{"key":"7736_CR48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.schres.2023.10.006","volume":"261","author":"L Huo","year":"2023","unstructured":"Huo L, Qu D, Pei C, Wu W, Ning Y, Zhou Y, Zhang XY. Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms. Schizophr Res. 2023;261:275\u201380.","journal-title":"Schizophr Res"},{"key":"7736_CR49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jpsychires.2025.04.025","volume":"186","author":"B Sui","year":"2025","unstructured":"Sui B, Li S, Wang P, Li X, Sun M, Bu Y, et al. Niacin skin Flushing response in patients with schizophrenia: associations with the efficacy of modified electroconvulsive therapy and clinical symptoms. J Psychiatr Res. 2025;186:226\u201334.","journal-title":"J Psychiatr Res"},{"key":"7736_CR50","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.scog.2025.100346","volume":"40","author":"M Ju","year":"2025","unstructured":"Ju M, Long B, Wei Y, Tang X, Xu L, Gan R, et al. Cognitive impairments in first-episode psychosis patients with attenuated niacin response. Schizophr Res Cogn. 2025;40:100346.","journal-title":"Schizophr Res Cogn"},{"issue":"1","key":"7736_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","volume":"61","author":"H Tavares","year":"2003","unstructured":"Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF. Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res. 2003;61(1):1\u20136.","journal-title":"Schizophr Res"},{"key":"7736_CR52","doi-asserted-by":"publisher","first-page":"8881770","DOI":"10.1155\/2021\/8881770","volume":"2021","author":"EA Ermakov","year":"2021","unstructured":"Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative Stress-Related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev. 2021;2021:8881770.","journal-title":"Oxid Med Cell Longev"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07736-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07736-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07736-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:02:14Z","timestamp":1767045734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07736-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7736"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07736-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that all experiments on human subjects were conducted in accordance with the Declaration of Helsinki and that all procedures were carried out with the adequate understanding and written consent of the subjects. All experimental protocols were approved by the Ethics Committee of The Affiliated Guangji Hospital of Soochow University. Informed consent was obtained from all the participants and\/or their legal guardians. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1175"}}